Clinical Trials List
Protocol Number114269 (FLU D-QIV-008)
2010-10-01 - 2011-09-30
Phase III
Terminated2
-
Trial Applicant
GlaxoSmithKline
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chiu-Shong Liu Division of Family Medicine
- Hua-Shui Hsu Division of Family Medicine
- Chih Hsueh Lin Division of Family Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
400 participants
-
Global
4600 participants